SLS - SELLAS Life Sciences Group, Inc.

QQQ $ 471.89 $ -0.82 (-0.17 %)

DIA $ 413.95 $ 2.61 (0.63 %)

SPY $ 559.30 $ -0.88 (-0.16 %)

TLT $ 97.51 $ -0.34 (-0.35 %)

GLD $ 232.94 $ 1.19 (0.51 %)

Previous Close

$ 1.3

Open

$ 1.29

Bid

$ 1.30 x 100

Ask

-- x --

Day's Range

$ 1.28 - $ 1.33

52 Week Range

$ 0.50 - $ 1.90

Volume

278,648

Average Volume

Market Cap

83.63M

Beta (5Y Monthly)

$ 1.23

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-28-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-16-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-31-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-23-2021	12-31-2020	10-K
16	11-13-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	03-13-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-14-2019	06-30-2019	10-Q
22	05-15-2019	03-31-2019	10-Q
23	03-22-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-14-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	04-13-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-15-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-09-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	03-10-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-07-2015	03-31-2015	10-Q
39	03-05-2015	12-31-2014	10-K
40	11-05-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

SELLAS Life Sciences Gr Q2 EPS $(0.13) Bea...
08/13/2024 20:54:10

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate o...

SELLAS Receives EMA Orphan Drug Designatio...
08/06/2024 12:45:46

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceuti...

SELLAS Life Sciences Enters $21M Securitie...
07/31/2024 12:33:26

SELLAS Announces U.S. FDA Rare Pediatric D...
07/16/2024 13:07:50

- Acute Myeloid Leukemia (AML) is the Second Most Common Hematological Malignancy in Children Often Associated with Poorer Prog...

SELLAS Life Sciences Granted Orphan Drug D...
07/08/2024 12:46:06

SELLAS Life Sciences Granted FDA Rare Pedi...
06/24/2024 13:05:45

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

SELLAS Life Sciences Announced Review Of O...
06/17/2024 13:07:34

– The Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Without Any Modifications ––...

$sellas-life-sciences-completes-enrollment-and-reports-positive-initial-data-from-phase-2a-trial-of-sls009-in-relapsedrefractory-acute-myeloid-leukemia$

SELLAS Life Sciences Completes Enrollment ...
06/10/2024 12:41:19

- 30 Patients Relapsed or Refractory to Venetoclax-Based Regimens Enrolled Ahead of Schedule - Overall Response Rate (ORR) of 3...

SELLAS Life Sciences Gr Q1 2024 Adj EPS $(...
05/14/2024 20:35:44

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate...

SELLAS Announces Phase 2 Preliminary Data ...
05/01/2024 12:36:39

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

SELLAS Life Sciences Announces Recommendat...
04/29/2024 12:55:53

– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of P...

SELLAS Life Sciences Gr Q4 EPS $(0.25) Mis...
03/29/2024 03:35:30

SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate...

Sellas Life Sciences Group Files For Mixed...
03/28/2024 20:50:59

-S-3

$sellas-announces-topline-data-from-phase-2a-study-of-sls009-in-relapsedrefractory-acute-myeloid-leukemia-and-provides-steering-committee-update-on-phase-3-regal-study$

SELLAS Announces Topline Data From Phase 2...
03/26/2024 11:37:44

Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Schedu...

dow-falls-over-200-points-adobe-shares-plunge

Dow Falls Over 200 Points; Adobe Shares Pl...
03/15/2024 18:40:28

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded...

Why Jabil Shares Are Trading Lower By Over...
03/15/2024 18:31:53

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter resu...

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/15/2024 17:31:09

crude-oil-edges-lower-us-consumer-sentiment-falls-in-march

Crude Oil Edges Lower; US Consumer Sentime...
03/15/2024 16:05:34

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday. The Dow traded do...